{"meta":{"query_hash":"a0ef99b9fb86","filters":{"venue":"Cell and Gene Therapy Insights"},"cohort_total":20,"direct_labels_cover":0,"predictions_cover":20,"exported":20,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a0ef99b9fb86","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cell+and+Gene+Therapy+Insights"},"results":[{"id":"W4225544007","doi":"10.18609/cgti.2022.024","title":"Developing stem cell therapies: expansion strategies and lessons learned","year":2022,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Medicine; Psychology; Biology; Cell biology","score_opus":0.11259295258256696,"score_gpt":0.330714023287791,"score_spread":0.21812107070522402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225544007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532667,0.040238176,0.00014255388,0.0011207912,0.00008688918,0.00043534773,0.0000025541115,0.0000517394,0.004655279],"genre_scores_gemma":[0.9751542,0.018935094,0.00030178626,0.0003938217,0.00006911371,0.000056768196,0.000014748697,0.00003379891,0.0050406693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984248,0.00021275757,0.00021144195,0.00042527186,0.0004118596,0.00031381508],"domain_scores_gemma":[0.9993369,0.00010731519,0.00006442632,0.00026679787,0.000060736256,0.00016385045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026976666,0.00020592922,0.0002959257,0.00014398513,0.0005991237,0.00009519412,0.00011303347,0.00006781453,0.00023959223],"category_scores_gemma":[0.0000012953556,0.00015573356,0.00004480207,0.0002236148,0.00009790043,0.00011091893,0.00013858233,0.00032103853,0.000008783789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058673864,0.00017315507,0.00032652845,0.00018341486,0.000057668465,0.00011896306,0.01642209,0.000021978889,0.88900495,0.0010873375,0.00016557006,0.091851585],"study_design_scores_gemma":[0.0064675426,0.002552644,0.0051083416,0.000059478778,0.000034640085,0.000114134404,0.043105762,0.00041488008,0.71639127,0.0045513664,0.22050823,0.00069169776],"about_ca_topic_score_codex":0.000058145546,"about_ca_topic_score_gemma":0.000008552766,"teacher_disagreement_score":0.22034267,"about_ca_system_score_codex":0.00005826619,"about_ca_system_score_gemma":0.00029822678,"threshold_uncertainty_score":0.63506305},"labels":[],"label_agreement":null},{"id":"W4248442927","doi":"10.18609/cgti.2015.026","title":"Commercial Insight – November 2015","year":2015,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Employment and Social Development Canada","funders":"","keywords":"Environmental science","score_opus":0.028045626360889087,"score_gpt":0.2586570089947548,"score_spread":0.2306113826338657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248442927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9243396,0.02778102,0.00007911713,0.009395291,0.00042039694,0.00018547867,9.4446847e-7,0.000095931275,0.03770221],"genre_scores_gemma":[0.9837091,0.006811179,0.00024930632,0.0044610477,0.00021710621,0.000004941664,0.000015185361,0.000015502352,0.004516659],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941444,0.000025252664,0.00012956676,0.0001808398,0.000100354875,0.00014951457],"domain_scores_gemma":[0.9995096,0.000013220256,0.000033090593,0.0002159267,0.000062737156,0.00016545843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006137896,0.00013078752,0.00020463213,0.000077778976,0.00007849097,0.000008011563,0.000057196186,0.0012516603,0.000071152164],"category_scores_gemma":[0.0000038326248,0.0000854957,0.000039065017,0.00012057347,0.00014041005,0.000039171937,0.000027237484,0.00076815166,0.00009561844],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047714394,0.002598583,0.0068947063,0.00009344495,0.00078484166,0.00074607873,0.02364022,0.000010576223,0.5839621,0.0068407306,0.24405783,0.12559949],"study_design_scores_gemma":[0.0039333575,0.0006397707,0.0022707346,0.000012660207,0.000032001168,0.00009643016,0.000081003906,0.000034014658,0.25804946,0.0009277949,0.7337583,0.00016448507],"about_ca_topic_score_codex":0.000019816387,"about_ca_topic_score_gemma":0.0000088836305,"teacher_disagreement_score":0.48970047,"about_ca_system_score_codex":0.000011168291,"about_ca_system_score_gemma":0.000058301885,"threshold_uncertainty_score":0.9653951},"labels":[],"label_agreement":null},{"id":"W4285509048","doi":"10.18609/cgti.2021.219","title":"Process development and scale-up of pluripotent stem cell manufacturing","year":2021,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Induced pluripotent stem cell; Process (computing); Process development; Scale (ratio); Manufacturing process; Manufacturing engineering; Computer science; Engineering; Biology; Materials science; Geography; Embryonic stem cell; Operating system; Genetics","score_opus":0.01458430121772456,"score_gpt":0.23349715146754516,"score_spread":0.2189128502498206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285509048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97887015,0.01973262,0.00012701075,0.000028337934,0.00006891261,0.00015502382,0.000003525918,0.000006071585,0.001008319],"genre_scores_gemma":[0.9890292,0.0064387517,0.00038878366,0.00007111534,0.00005049443,0.000013356969,0.000037170426,0.000019137424,0.0039519668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894375,0.000055646386,0.000206731,0.00039682304,0.00018038123,0.00021665607],"domain_scores_gemma":[0.99949765,0.000008392056,0.000064304804,0.00021884378,0.000091088594,0.00011972632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083088154,0.00016675526,0.00017391305,0.000041601998,0.000109803324,0.000023764951,0.00010905675,0.00010804603,0.000011697806],"category_scores_gemma":[7.446862e-7,0.00013836629,0.00003652745,0.000049490005,0.00006896064,0.000004738525,0.0001176192,0.000075645556,0.0000030304086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009509368,0.00008909531,0.00020717591,0.00016377427,0.000032195978,0.000012797173,0.0009926021,0.000018487373,0.98234046,8.138919e-7,0.000030034304,0.01601748],"study_design_scores_gemma":[0.000998124,0.00011779937,0.0008849271,0.00001495997,0.000005299994,0.000015984337,0.00027737048,0.00001497208,0.9806247,0.000025485402,0.016844375,0.00017602659],"about_ca_topic_score_codex":0.0000030336946,"about_ca_topic_score_gemma":0.000009429989,"teacher_disagreement_score":0.016814342,"about_ca_system_score_codex":0.000007330333,"about_ca_system_score_gemma":0.00011555563,"threshold_uncertainty_score":0.56424135},"labels":[],"label_agreement":null},{"id":"W4292264022","doi":"10.18609/cgti.2022.111","title":"Manufacturing considerations underpinning viral and non-viral platform selection","year":2022,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Engineering management; Product (mathematics); Engineering; New product development; Management","score_opus":0.010971468951418132,"score_gpt":0.22745895165903926,"score_spread":0.21648748270762114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292264022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535596,0.0029982098,0.00032495728,0.00004891428,0.00018635676,0.00016498943,0.000008928526,0.000018970168,0.0008926878],"genre_scores_gemma":[0.9973161,0.00089508964,0.00015136719,0.00080030086,0.00018945725,0.00005267718,0.000053745018,0.00001840373,0.0005228236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992619,0.00004379862,0.00013491714,0.00030485852,0.00009022825,0.00016429285],"domain_scores_gemma":[0.99971163,0.000010421907,0.000057641268,0.00012070488,0.000019025627,0.00008060318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051249874,0.00014739005,0.00010362827,0.000053281005,0.0009137469,0.000059413353,0.00004396811,0.00006050595,0.0000861729],"category_scores_gemma":[0.0000022005588,0.00013493803,0.000046204797,0.000030407235,0.00004881489,0.000010816114,0.00010868966,0.00011604413,0.0000013604425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001006304,0.000072966075,0.0004900799,0.000008966411,0.000042043484,0.0000037549803,0.00042733838,0.0010436837,0.99466383,0.00007496579,0.0017636821,0.0013080706],"study_design_scores_gemma":[0.0012033565,0.00089961983,0.0023213557,0.0000029845835,0.00001163417,0.00006007456,0.00018543167,0.0002590874,0.974694,0.004156563,0.015937343,0.00026852926],"about_ca_topic_score_codex":0.00004137931,"about_ca_topic_score_gemma":0.000013251566,"teacher_disagreement_score":0.019969799,"about_ca_system_score_codex":0.00001269146,"about_ca_system_score_gemma":0.00004160538,"threshold_uncertainty_score":0.7027895},"labels":[],"label_agreement":null},{"id":"W4316924672","doi":"10.18609/cgti.2022.209","title":"Innovating in iPSC differentiation & engineering","year":2022,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"VLSI and FPGA Design Techniques","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Cell biology; Engineering; Biology","score_opus":0.011583485698980522,"score_gpt":0.18147300390203616,"score_spread":0.16988951820305564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316924672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906726,0.0028374516,0.0054523046,0.0000070419173,0.00012299823,0.000107925815,0.0000015927567,0.0002301982,0.0005678731],"genre_scores_gemma":[0.99830586,0.00048800325,0.00096523325,0.00003943524,0.00004117986,0.000054369968,0.000018898008,0.000022461403,0.000064569096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995488,0.00001643262,0.00013563149,0.000102948805,0.00007526665,0.0001209518],"domain_scores_gemma":[0.9998481,0.000015313295,0.000015218588,0.000094036455,0.000007409559,0.000019915002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064044296,0.00009909409,0.00009821755,0.00015352208,0.00006594414,0.000017179815,0.000063565996,0.000029835055,0.000046566733],"category_scores_gemma":[0.0000010089208,0.00009830696,0.000015472478,0.00022276331,0.000004460242,0.000052020026,0.000023092984,0.00015781757,0.0000015857929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000074414475,0.000033346078,0.00051013107,0.00002613228,0.000010996936,0.000004439097,0.0023899258,0.009543923,0.9594152,0.00017422209,0.00017969198,0.027704556],"study_design_scores_gemma":[0.0016254783,0.00019726792,0.010255663,0.00002396373,0.000006425315,0.000015684742,0.0001002053,0.12224821,0.80477923,0.002240778,0.057632692,0.0008744126],"about_ca_topic_score_codex":0.0000065216514,"about_ca_topic_score_gemma":0.0000028497116,"teacher_disagreement_score":0.15463598,"about_ca_system_score_codex":0.00003223316,"about_ca_system_score_gemma":0.0000034699688,"threshold_uncertainty_score":0.40088418},"labels":[],"label_agreement":null},{"id":"W4318484555","doi":"10.18609/cgti.2022.210","title":"Process development optimization for GMP manufacturing: a CAR-T case study","year":2022,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Manufacturing Process and Optimization","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Manufacturing engineering; Process (computing); Computer science; Engineering","score_opus":0.016114495802407973,"score_gpt":0.2185807969203052,"score_spread":0.2024663011178972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318484555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98022383,0.0010058657,0.017607395,0.000005688912,0.0001654853,0.0006991192,0.0000031723755,0.00013937091,0.00015005223],"genre_scores_gemma":[0.9971102,0.00012482514,0.0020010888,0.00003508055,0.00004343869,0.00045939442,0.000033024175,0.000036099013,0.00015684468],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993483,0.00001697969,0.00016890885,0.00020500655,0.000113417685,0.00014741925],"domain_scores_gemma":[0.9997715,0.000013600099,0.000034198747,0.000104779174,0.000025377914,0.000050554372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006714993,0.0001545691,0.00012539724,0.00008607743,0.00047293768,0.000040451312,0.00007680639,0.000027307662,0.000074248885],"category_scores_gemma":[5.296871e-7,0.00014067153,0.000018754201,0.00006281733,0.0000067631304,0.00007355694,0.000023573333,0.00007669147,4.3355604e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031881795,0.000108970155,0.00002253628,0.00007768955,0.00003148628,0.00004469406,0.014307628,0.9777342,0.00012432397,8.815198e-7,0.000021149066,0.0074945763],"study_design_scores_gemma":[0.00438851,0.00067888986,0.0001203408,0.000007320477,0.000040177238,0.00022993337,0.007809531,0.36294916,0.60268605,0.00014117468,0.020042028,0.00090689183],"about_ca_topic_score_codex":0.000008723296,"about_ca_topic_score_gemma":0.000007995293,"teacher_disagreement_score":0.614785,"about_ca_system_score_codex":0.000036197973,"about_ca_system_score_gemma":0.000021452497,"threshold_uncertainty_score":0.57364184},"labels":[],"label_agreement":null},{"id":"W4390676948","doi":"10.18609/cgti.2023.205","title":"Is bigger better? Modeling AAV production to find optimization opportunities","year":2023,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Assembly Line Balancing Optimization","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Production (economics); Computer science; Economics; Microeconomics","score_opus":0.04567992508525502,"score_gpt":0.22475578693755682,"score_spread":0.1790758618523018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390676948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9142866,0.00055622956,0.08320941,0.0004438586,0.00039460964,0.00020639053,0.0000029574173,0.00043918213,0.00046076672],"genre_scores_gemma":[0.9855761,0.006104013,0.0061981194,0.0003492399,0.00036545552,0.00003521568,0.00009886232,0.000064772306,0.0012082214],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993567,0.000015750422,0.00016186573,0.00019573122,0.000108752676,0.00016119545],"domain_scores_gemma":[0.99968576,0.000008622815,0.000018797355,0.00016387674,0.000058442944,0.000064504406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065918925,0.00014282482,0.000118806354,0.00019966981,0.000111742615,0.00004437912,0.00005446558,0.000066027475,0.00001904024],"category_scores_gemma":[0.0000031019345,0.00013496465,0.000021496491,0.00027694754,0.000008141346,0.00015488085,0.000015604763,0.00005804802,0.000025867583],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000074307177,0.000006688136,0.0000111825975,0.00001803559,0.000011484069,0.0000013995996,0.0025282747,0.9585125,0.032890245,0.0000032470307,0.0013665871,0.0046429425],"study_design_scores_gemma":[0.00016389308,0.000030047706,0.000050963066,0.000013467824,0.0000053198023,0.0000013496056,0.00012745791,0.9236729,0.074156426,0.00008473551,0.0015144274,0.00017898346],"about_ca_topic_score_codex":0.0000044533426,"about_ca_topic_score_gemma":0.0000013309376,"teacher_disagreement_score":0.077011295,"about_ca_system_score_codex":0.000019367359,"about_ca_system_score_gemma":0.000009622651,"threshold_uncertainty_score":0.55036986},"labels":[],"label_agreement":null},{"id":"W4390676983","doi":"10.18609/cgti.2023.187","title":"Enabling cell culture technologies for the intensification & scale-up of viral vector manufacturing","year":2023,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Viral vector; Scale (ratio); Cell culture; Vector (molecular biology); Virology; Computer science; Manufacturing engineering; Engineering; Chemistry; Biology; Geography; Biochemistry; Recombinant DNA; Genetics; Cartography","score_opus":0.02806008795911264,"score_gpt":0.278736637286289,"score_spread":0.25067654932717637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390676983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986444,0.012291205,0.0003127569,0.00023263166,0.000120652796,0.0004428041,0.000015396303,0.000053783268,0.00008675727],"genre_scores_gemma":[0.9794633,0.017981596,0.00017314087,0.000081721664,0.0001255136,0.00008143031,0.00009954512,0.000026864116,0.00196688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991315,0.000032030384,0.00016723905,0.00031290916,0.00011983753,0.00023648735],"domain_scores_gemma":[0.99937004,0.000033322536,0.000077829696,0.00037333742,0.00011447199,0.00003102303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017756748,0.0001591363,0.00013882564,0.00007860684,0.00020557287,0.000030420508,0.00027764394,0.00016605495,0.0000054622524],"category_scores_gemma":[0.0000113631495,0.00010190797,0.00008831718,0.00012219218,0.00014646567,0.000005229917,0.000080358164,0.000107623506,0.000007662515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000779342,0.000025397288,0.000020826643,0.000029594452,0.000034787456,2.3042922e-7,0.00061119377,0.00005021,0.9860968,0.0000059639433,0.0009083611,0.011437272],"study_design_scores_gemma":[0.0007313132,0.0006907767,0.00009205355,0.0000051391985,0.000008074276,0.0000011905776,0.0006171102,0.00007777937,0.94199014,0.00033762716,0.05531827,0.00013054155],"about_ca_topic_score_codex":0.0000069765397,"about_ca_topic_score_gemma":0.000033253997,"teacher_disagreement_score":0.05440991,"about_ca_system_score_codex":0.000007233697,"about_ca_system_score_gemma":0.000026892127,"threshold_uncertainty_score":0.41556865},"labels":[],"label_agreement":null},{"id":"W4390679371","doi":"10.18609/cgti.2023.178","title":"Enabling patient access to CAR-T cell therapy in India","year":2023,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences","funders":"","keywords":"Medicine","score_opus":0.03822987937315814,"score_gpt":0.2929378275758596,"score_spread":0.2547079482027015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390679371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921743,0.004155701,0.000018452478,0.0016874319,0.00022269598,0.00045420812,0.0000017819336,0.000046151396,0.0012392424],"genre_scores_gemma":[0.983294,0.013060766,0.000050491715,0.002936646,0.00014515697,0.000025536652,0.000036284142,0.000019172807,0.00043194016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905,0.00004212103,0.00020317189,0.00025713895,0.00023757861,0.00020997394],"domain_scores_gemma":[0.999522,0.00004211144,0.00004074839,0.00016865482,0.00004965322,0.0001768582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001335873,0.00012852669,0.00019163605,0.00027809304,0.00008192592,0.000035362955,0.00007651433,0.00016873848,0.000047407826],"category_scores_gemma":[0.0000027224226,0.00008509669,0.000039074523,0.00060768996,0.00007556309,0.00004952628,0.000041057578,0.0001830253,0.000023316079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049211184,0.00034304496,0.0020905673,0.0000762296,0.000028582977,0.000098633245,0.020329984,0.000055936678,0.6699653,0.000075041185,0.00093397923,0.30551058],"study_design_scores_gemma":[0.004566821,0.0013187214,0.115418874,0.00007658029,0.000007197351,0.000004159634,0.00041738604,0.00037616724,0.7585485,0.0024049396,0.11655874,0.00030190177],"about_ca_topic_score_codex":0.000055764118,"about_ca_topic_score_gemma":0.000009098254,"teacher_disagreement_score":0.30520868,"about_ca_system_score_codex":0.00002004052,"about_ca_system_score_gemma":0.00006481176,"threshold_uncertainty_score":0.34701425},"labels":[],"label_agreement":null},{"id":"W4390679400","doi":"10.18609/cgti.2023.195","title":"Current issues & future trends in cryopreservation for advanced therapies","year":2023,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Reproductive Health and Technologies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; National Institutes of Health; Panthera","keywords":"Cryopreservation; Current (fluid); Intensive care medicine; Medicine; Risk analysis (engineering); Engineering ethics; Engineering; Biology; Fishery","score_opus":0.06216544241441164,"score_gpt":0.3603320566345505,"score_spread":0.29816661422013885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390679400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90926033,0.08464993,0.000023862432,0.005088851,0.0002616726,0.00037535658,0.0000036435222,0.00016580684,0.00017055393],"genre_scores_gemma":[0.8788891,0.11659526,0.00093881384,0.00022335499,0.0006099906,0.00021653766,0.00019158909,0.000022799206,0.0023125736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992649,0.000019418743,0.0001534144,0.00028297908,0.000089835026,0.00018944542],"domain_scores_gemma":[0.99958235,0.000025734882,0.00004281381,0.00024845786,0.000060264545,0.000040361636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098585326,0.000119189295,0.00020193768,0.00028063238,0.00008237858,0.000009470903,0.000051285773,0.000077154175,0.000014447442],"category_scores_gemma":[0.000011175409,0.000081153055,0.000038635422,0.00043199072,0.000042152533,0.000069112706,0.000013740608,0.0001078448,0.0000059813847],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008409726,0.00015912353,0.0047522085,0.00014693876,0.000021049636,0.000002800472,0.0046860813,0.0000059438403,0.10368682,0.0005962442,0.0052864593,0.87981534],"study_design_scores_gemma":[0.002274294,0.00041321648,0.08638843,0.000025030498,0.000004899754,0.0000013821036,0.00041085877,0.000029750261,0.06938038,0.011885106,0.8290632,0.00012346289],"about_ca_topic_score_codex":0.0000070559504,"about_ca_topic_score_gemma":0.000019076551,"teacher_disagreement_score":0.8796919,"about_ca_system_score_codex":0.000013809873,"about_ca_system_score_gemma":0.000017591605,"threshold_uncertainty_score":0.33093256},"labels":[],"label_agreement":null},{"id":"W4401691029","doi":"10.18609/cgti.2024.052","title":"Clinical trial applications for investigational medicinal products that contain or consist of genetically modified organisms: industry experiences under the European Union Clinical Trial Regulation (536/2014)","year":2024,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"European union; Clinical trial; Medicine; Genetically modified organism; Business; Biotechnology; Biology; International trade; Internal medicine; Genetics","score_opus":0.1905114425597662,"score_gpt":0.3988132931859616,"score_spread":0.20830185062619538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401691029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960769,0.002907723,0.016642604,0.01466065,0.0012950485,0.0032135367,0.000009174993,0.000053030235,0.00044925863],"genre_scores_gemma":[0.9925925,0.0011494786,0.0010596768,0.0008908025,0.003470328,0.00014823135,0.0001420575,0.000025414152,0.00052148796],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971054,0.00087415223,0.0009554275,0.0004840558,0.0004302691,0.00015067299],"domain_scores_gemma":[0.9980258,0.0010031788,0.0002287524,0.00031139064,0.00023081238,0.0002000622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003371086,0.00017169131,0.00037813757,0.00007252069,0.00020642355,0.00004749325,0.0001306712,0.00046963958,0.00006425154],"category_scores_gemma":[0.00012013818,0.00008909372,0.00012239565,0.00022811785,0.0022853033,0.000050283743,0.00003335544,0.0005145448,0.0000030781698],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26356515,0.0042603128,0.00024653468,0.00078459946,0.0012493621,0.000026862264,0.015242509,0.00005056696,0.0730077,0.07162463,0.010287719,0.55965406],"study_design_scores_gemma":[0.55813605,0.028862106,0.02218339,0.0006033098,0.0011755486,0.000099252466,0.0075022834,0.007843466,0.05849553,0.10069877,0.2131943,0.0012059892],"about_ca_topic_score_codex":0.0000059706063,"about_ca_topic_score_gemma":0.0000050389413,"teacher_disagreement_score":0.5584481,"about_ca_system_score_codex":0.000016763723,"about_ca_system_score_gemma":0.0007994968,"threshold_uncertainty_score":0.8420296},"labels":[],"label_agreement":null},{"id":"W4402802170","doi":"10.18609/cgti.2024.107","title":"iPSC-based therapy dilemmas explored: overcoming hurdles for future success","year":2024,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Engineering ethics; Management science; Medicine; Risk analysis (engineering); Intensive care medicine; Engineering","score_opus":0.016453342975949217,"score_gpt":0.24642347619303503,"score_spread":0.22997013321708581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402802170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8831038,0.113722295,0.0016472182,0.0002780781,0.0006739576,0.00030385077,0.00005628547,0.000023799757,0.00019071797],"genre_scores_gemma":[0.9536115,0.042370312,0.00054869236,0.0010087987,0.0018173443,0.0000999835,0.00023336538,0.0000507091,0.00025929033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991198,0.000022976154,0.00015775184,0.00041159915,0.00007554466,0.0002123354],"domain_scores_gemma":[0.99953085,0.00005029847,0.000035320492,0.00025064623,0.00004779139,0.00008506382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007008895,0.0002146385,0.00015520587,0.000051932595,0.0001450332,0.000120685974,0.00013362347,0.00014923023,0.00001824512],"category_scores_gemma":[0.0000031159898,0.00016888649,0.00012385251,0.00006507053,0.000054335836,0.0000061382793,0.00002664064,0.00006706797,0.0000025521247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044113086,0.0000888916,0.00016283918,0.00005786787,0.0000854498,0.000007737162,0.00056610676,0.0001327114,0.953025,0.00036493162,0.0033838411,0.041683488],"study_design_scores_gemma":[0.00084961054,0.00034942507,0.0001299856,0.0000096304575,0.0000075502576,0.0000017631373,0.00004886121,0.00026322666,0.5256194,0.00047275823,0.4720612,0.00018664499],"about_ca_topic_score_codex":0.00001410549,"about_ca_topic_score_gemma":0.000022955808,"teacher_disagreement_score":0.46867734,"about_ca_system_score_codex":0.000010514148,"about_ca_system_score_gemma":0.00010011451,"threshold_uncertainty_score":0.68869907},"labels":[],"label_agreement":null},{"id":"W4417329705","doi":"10.18609/cgti.2025.034","title":"CAR-T manufacturing intensification: the next wave of CAR-T commercialization","year":2025,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Medical Association","funders":"","keywords":"Commercialization; Manufacturing; Manufacturing sector; Advanced manufacturing; Intersection (aeronautics); Health care","score_opus":0.062189352294689616,"score_gpt":0.29876343330783983,"score_spread":0.23657408101315022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417329705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782938,0.007884405,0.0002878188,0.0015763782,0.00019292759,0.00058999227,0.0000019257031,0.0000276,0.011145189],"genre_scores_gemma":[0.98250693,0.007920393,0.00006552053,0.0011763504,0.00013299634,0.000022309536,0.000029130682,0.000017174852,0.008129214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903935,0.00010230691,0.00025637425,0.0002265474,0.00020875274,0.00016664597],"domain_scores_gemma":[0.9991053,0.00011399509,0.00006823711,0.00046620195,0.00018603627,0.000060232698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016646092,0.00014573871,0.00026108808,0.00013663045,0.00017004715,0.00003333973,0.00010942974,0.000092366114,0.00029439354],"category_scores_gemma":[0.000009092733,0.00009244479,0.000080545455,0.00021854108,0.00018048697,0.000049173283,0.00004367757,0.00018153961,0.000004522456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005169902,0.000112498274,0.00049359276,0.0000835738,0.00012701192,0.0000066886632,0.004175512,0.000008012203,0.89864796,0.0004415268,0.0008728716,0.09451378],"study_design_scores_gemma":[0.0013059383,0.00015457539,0.0089077875,0.000038985894,0.00003471294,0.000009499612,0.0006091747,0.0002280545,0.89843845,0.00070424046,0.089481495,0.00008709766],"about_ca_topic_score_codex":0.00013478323,"about_ca_topic_score_gemma":0.000028328328,"teacher_disagreement_score":0.094426684,"about_ca_system_score_codex":0.0000399683,"about_ca_system_score_gemma":0.00008388807,"threshold_uncertainty_score":0.3769789},"labels":[],"label_agreement":null},{"id":"W4417334990","doi":"10.18609/cgti.2025.008","title":"Driving innovation in cell and gene therapy: the role of AI and robotics","year":2025,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"OmniActive Health Technologies (Canada)","funders":"","keywords":"Robotics; Pharmaceutical industry; Field (mathematics); Robot","score_opus":0.017972079512783453,"score_gpt":0.2777696302803272,"score_spread":0.25979755076754374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417334990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555563,0.039965775,0.000110642046,0.00082177133,0.00005695157,0.00057458464,0.0000013710089,0.000015048605,0.0028975664],"genre_scores_gemma":[0.96574754,0.030779622,0.00023393979,0.0008730275,0.00007395213,0.00001702312,0.000009817467,0.000021779222,0.0022433198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884045,0.00010667169,0.00034153953,0.00029486424,0.00019693979,0.00021952126],"domain_scores_gemma":[0.9992913,0.00012995284,0.000077274424,0.00030877854,0.0001382227,0.000054481825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033572773,0.0001869078,0.00031653314,0.00031922734,0.00011972118,0.000042277676,0.00009254916,0.00012511661,0.000054527136],"category_scores_gemma":[0.000008474121,0.00012339684,0.000031366148,0.00061968615,0.00019414649,0.000062316285,0.000060018225,0.00029693783,7.8271074e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035694268,0.00015268128,0.020080093,0.000041869367,0.00004676702,0.0000046831083,0.002729525,0.000022692673,0.8954117,0.0003634872,0.00003921077,0.080750406],"study_design_scores_gemma":[0.0038060236,0.0004372071,0.027226739,0.000048790986,0.000015544014,0.000008325798,0.00037041644,0.0011177391,0.9463578,0.0047484203,0.015716977,0.00014603321],"about_ca_topic_score_codex":0.0000837893,"about_ca_topic_score_gemma":0.00003968655,"teacher_disagreement_score":0.080604374,"about_ca_system_score_codex":0.000024301162,"about_ca_system_score_gemma":0.00010415723,"threshold_uncertainty_score":0.5031977},"labels":[],"label_agreement":null},{"id":"W7114797554","doi":"10.18609/cgti.2025.137","title":"A decade of innovation: perspectives from the Cell and Gene Therapy Insights Editorial Advisory Board","year":2025,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Advisory committee; Snapshot (computer storage); Genetic enhancement; Heading (navigation); Cell therapy","score_opus":0.006957399436092769,"score_gpt":0.2524517953633861,"score_spread":0.2454943959272933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7114797554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.887355,0.10911246,0.0010308191,0.000104654704,0.0016399717,0.00021875779,0.000010506838,0.000011050612,0.0005167412],"genre_scores_gemma":[0.96261567,0.032366987,0.00035458192,0.00027418777,0.0039910404,0.000019874426,0.000045189685,0.000018827122,0.00031365393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990232,0.00005986526,0.000259519,0.0003802738,0.00012451681,0.00015261293],"domain_scores_gemma":[0.99932784,0.00004646503,0.00008078612,0.00033280422,0.00017171136,0.00004041683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007910951,0.00021908108,0.00020049365,0.000071589115,0.00014231929,0.000033287823,0.00016902559,0.00019670099,0.000008566409],"category_scores_gemma":[0.000010024162,0.00015330903,0.000051569732,0.00021732622,0.00012988532,0.000006244567,0.000068560694,0.00012564409,6.7135824e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024385481,0.000080284386,0.00023862292,0.00000964087,0.000088017994,7.486916e-7,0.0027713203,0.00003610811,0.9907299,0.000080888145,0.0027651442,0.0029554714],"study_design_scores_gemma":[0.0015761079,0.00023393599,0.0020787446,0.00000835901,0.000012777623,6.4126635e-7,0.0005069541,0.000020120115,0.8582882,0.00059823546,0.13651079,0.0001651255],"about_ca_topic_score_codex":0.00005002359,"about_ca_topic_score_gemma":0.000016161504,"teacher_disagreement_score":0.13374564,"about_ca_system_score_codex":0.000006747526,"about_ca_system_score_gemma":0.00007877974,"threshold_uncertainty_score":0.6251761},"labels":[],"label_agreement":null},{"id":"W7115194976","doi":"10.18609/cgti.2025.013","title":"Enhancing CAR-T therapy development: harnessing cell selection flexibility","year":2025,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Lonza (Canada)","funders":"","keywords":"Flexibility (engineering); Automation; Cellular manufacturing; Selection (genetic algorithm); Product (mathematics); Upstream (networking); Isolation (microbiology)","score_opus":0.032145931485373466,"score_gpt":0.3007684147657189,"score_spread":0.26862248328034544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115194976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96636146,0.01733366,0.00085356535,0.00014836727,0.00024067308,0.00074394257,7.422219e-7,0.00013173862,0.014185867],"genre_scores_gemma":[0.9600477,0.006186847,0.001189123,0.000850104,0.00020329111,0.00005580018,0.000023694569,0.000042476247,0.031400956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980202,0.00015904232,0.00040930256,0.00062947476,0.00033471873,0.0004472896],"domain_scores_gemma":[0.9990484,0.00010506785,0.00007987537,0.00038377542,0.0002095148,0.00017336925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040116298,0.000322293,0.00043232227,0.00029806807,0.0004901843,0.00009574525,0.00013012292,0.00020270632,0.0007001573],"category_scores_gemma":[0.000007857682,0.00025522185,0.00010873093,0.0005790945,0.00011695455,0.00011369494,0.00004620546,0.00038319506,0.000023827388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088525855,0.0002999138,0.0020031615,0.00009965831,0.00007981136,0.0000080843665,0.003017553,0.0000046000473,0.87389785,0.000011796084,0.00009737458,0.11959493],"study_design_scores_gemma":[0.0032939925,0.00025484673,0.00597842,0.000054244956,0.000012894077,0.000008365471,0.00015437402,0.000097566095,0.8817779,0.00030423707,0.107840225,0.00022293336],"about_ca_topic_score_codex":0.00007544933,"about_ca_topic_score_gemma":0.000060451952,"teacher_disagreement_score":0.119371995,"about_ca_system_score_codex":0.00018186773,"about_ca_system_score_gemma":0.00054434786,"threshold_uncertainty_score":0.99999},"labels":[],"label_agreement":null},{"id":"W7115567204","doi":"10.18609/cgti.2024.167","title":"From the lab to the bench: scaling up regulatory T cell therapy","year":2024,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Effector; Automation; T cell; Cell therapy; Immune system; Portfolio; Key (lock); Regulatory T cell","score_opus":0.03740910209825789,"score_gpt":0.2891359515679986,"score_spread":0.2517268494697407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115567204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87331754,0.11480631,0.00006145524,0.0056459964,0.00083601184,0.0009484745,0.000015515165,0.00011080464,0.0042578885],"genre_scores_gemma":[0.93921286,0.024437716,0.00009398914,0.005994687,0.0023666797,0.000077122015,0.000036490444,0.000093031165,0.027687417],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978697,0.00023829946,0.00029207204,0.00059874373,0.000575801,0.00042541086],"domain_scores_gemma":[0.9982229,0.0004494775,0.000037291276,0.0009633898,0.00009401169,0.00023295006],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005236057,0.00032381967,0.00031609632,0.00010866857,0.00038902546,0.00023800091,0.0003832627,0.00014978452,0.0019251226],"category_scores_gemma":[0.0000062534064,0.00015461569,0.00018937072,0.00047602804,0.00018253383,0.000073002106,0.00008815376,0.0005248422,0.00022621019],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006751302,0.000100274476,0.00011353478,0.000022626597,0.00017092418,0.000046807883,0.023697853,0.000015349908,0.7836264,0.000073467505,0.0172879,0.17416975],"study_design_scores_gemma":[0.0011166362,0.00027104007,0.0015988937,0.000041244075,0.000021590604,0.000011362721,0.0006053919,0.00020641093,0.41786993,0.0007828409,0.57730263,0.00017201799],"about_ca_topic_score_codex":0.00028276726,"about_ca_topic_score_gemma":0.000033634136,"teacher_disagreement_score":0.5600147,"about_ca_system_score_codex":0.000056829034,"about_ca_system_score_gemma":0.00017432022,"threshold_uncertainty_score":0.99898726},"labels":[],"label_agreement":null},{"id":"W7118641193","doi":"10.18609/cgti.2020.045","title":"Drawing parallels and cross-pollinating ideas between viral vector and vaccine fields","year":2020,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Parallels; Process (computing); Technology transfer; Manufacturing process; Process development; Bioprocess; Section (typography); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","score_opus":0.01364945176023542,"score_gpt":0.2599591555597697,"score_spread":0.24630970379953426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7118641193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815536,0.01742037,0.00032771975,0.0002176449,0.00006369746,0.00013276198,0.000009441238,0.000018116692,0.0002566547],"genre_scores_gemma":[0.99424314,0.0037443552,0.00013158954,0.0011165263,0.00057867594,0.000009336014,0.000029495664,0.00001829116,0.00012859501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991769,0.00004563626,0.00016966528,0.0003718353,0.00006746338,0.00016849198],"domain_scores_gemma":[0.9995726,0.0000184168,0.000060747014,0.00012145268,0.00003245645,0.0001943318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004223207,0.00017658451,0.00017222743,0.000018998484,0.00024644256,0.00008841217,0.000066717876,0.00013794025,0.000015968451],"category_scores_gemma":[0.000012739426,0.00014298965,0.000044488046,0.00004089707,0.000052326868,0.000010775745,0.00010200544,0.00009132157,0.0000014119272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022646505,0.000032755608,0.029921154,0.000057046953,0.00007494844,0.0000074597265,0.00087936805,0.00004175485,0.96098536,0.00003693449,0.0006080411,0.007128719],"study_design_scores_gemma":[0.0029842048,0.0016705212,0.044834495,0.000019127394,0.000028769491,0.000009100807,0.00006611785,0.00023839154,0.9290094,0.0014321494,0.019207947,0.0004998236],"about_ca_topic_score_codex":0.000018415414,"about_ca_topic_score_gemma":0.0000031316301,"teacher_disagreement_score":0.031976,"about_ca_system_score_codex":0.0000020864582,"about_ca_system_score_gemma":0.000016145808,"threshold_uncertainty_score":0.5830949},"labels":[],"label_agreement":null},{"id":"W7122431200","doi":"10.18609/cgti.2022.246","title":"Process & analytical insights for GMP manufacturing of mRNA lipid nanoparticles","year":2022,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Manufacturing process; Process (computing); Messenger RNA; Product (mathematics); RNA; Software deployment; Key (lock); New product development","score_opus":0.02028146037924745,"score_gpt":0.2551450798181778,"score_spread":0.23486361943893036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7122431200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947191,0.004450633,0.00011594667,0.000046780246,0.00012286194,0.0002129455,0.000015187097,0.000008007031,0.00030857802],"genre_scores_gemma":[0.9976337,0.0009650799,0.00009357064,0.00026343684,0.00015188094,0.00006465106,0.00007601013,0.00001732857,0.00073432026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991318,0.000045468318,0.00021073593,0.0003139604,0.000118770724,0.00017923872],"domain_scores_gemma":[0.9995491,0.000014550945,0.00008140483,0.00022756547,0.00005920946,0.00006818216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066975605,0.00014713297,0.00017233468,0.000056242072,0.00019412745,0.000014377328,0.00017735381,0.00005999055,0.000040552954],"category_scores_gemma":[0.000003911069,0.00012194931,0.00008763364,0.000054610613,0.00006564879,0.000005789591,0.00007899908,0.00006686317,0.0000019591491],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045855917,0.00014288798,0.00012226164,0.000027188566,0.000056743665,0.0000012560058,0.00073958613,0.00026414075,0.995202,0.00002350413,0.00043060826,0.0025312412],"study_design_scores_gemma":[0.0007507375,0.00077959796,0.00020867205,0.000003461065,0.000013784931,0.0000061163123,0.0001894278,0.00009809495,0.9431394,0.0005523152,0.05409037,0.00016803191],"about_ca_topic_score_codex":0.0000069207013,"about_ca_topic_score_gemma":0.000012074602,"teacher_disagreement_score":0.053659763,"about_ca_system_score_codex":0.000006357328,"about_ca_system_score_gemma":0.00004442127,"threshold_uncertainty_score":0.49729487},"labels":[],"label_agreement":null},{"id":"W7123667155","doi":"10.18609/cgti.2020.195","title":"Under construction: roadmaps for HTA, pricing and reimbursement of cell and gene therapies","year":2020,"lang":"en","type":"article","venue":"Cell and Gene Therapy Insights","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health care; Health economics; Strategic planning; Primary care; Pricing strategies","score_opus":0.06493991700503458,"score_gpt":0.24846393984950116,"score_spread":0.18352402284446656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7123667155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95175433,0.042655624,0.0010219592,0.001570148,0.00011188344,0.00026698067,0.000059437392,0.000010387948,0.0025492301],"genre_scores_gemma":[0.9653489,0.030398177,0.001511155,0.002456818,0.00015367582,0.00001246198,0.0000071566387,0.000017298971,0.00009436073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999159,0.000010302157,0.00034608928,0.00031066744,0.000015891786,0.00015807377],"domain_scores_gemma":[0.9995237,0.000047594447,0.00017343827,0.00010455289,0.000017570128,0.00013313872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098307035,0.000145405,0.00032346827,0.000062471794,0.00010931914,0.00004522887,0.00006267518,0.000067369256,0.00005206297],"category_scores_gemma":[0.0000023529842,0.00014003253,0.00004602721,0.000056121207,0.00012024237,0.000079789796,0.000033607033,0.00006670634,0.0000040527048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013550313,0.00062667514,0.02032582,0.0010382384,0.0010301138,0.0000064568794,0.03793266,0.00040676072,0.48225185,0.37718773,0.0019213937,0.07591725],"study_design_scores_gemma":[0.008118531,0.0011147286,0.005338894,0.000015681975,0.000039009734,0.000010683782,0.0006952303,0.006898325,0.5539309,0.15207192,0.270887,0.0008791423],"about_ca_topic_score_codex":0.000020671861,"about_ca_topic_score_gemma":0.000002069516,"teacher_disagreement_score":0.26896557,"about_ca_system_score_codex":0.000010374581,"about_ca_system_score_gemma":0.0000122272195,"threshold_uncertainty_score":0.5710361},"labels":[],"label_agreement":null}]}